Vés al contingut

A phase 3, multicenter, double blind, placebo-controlled, randomized withdrawal trial to evaluate the efficacy, safety, and pharmacokinetics of deucravacitinib in children and adolescents from 5 to less than 18 years of age with active juvenile psoriatic arthritis

Obert
  • Codi protocol: IM011-1071
  • Codi EudraCT: No aplica
  • Grup de recerca: Reumatologia
  • Servei: Reumatologia
  • Investigador/a principal:  Lopez Corbeto, Mireia
  • Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Fase: Fase III